Women’s Health & OB/GYN News

Mode of delivery did not affect self-perceived sexual life satisfaction overall or at any time postpartum, according to cohort study results published in the American Journal of Obstetrics and Gynecology.

As we enter the second half of 2024, it is important to understand some tax law changes that became effective this year and could affect your retirement savings and tax planning.

The AMA House of Delegates adopted several new policies to promote public health at its annual meeting.

Metformin exposure during pregnancy was not associated with adverse childhood neurodevelopmental outcomes up to age 14 years, according to a systematic review and meta-analysis published in the American Journal of Obstetrics and Gynecology.

Infants born to mothers vaccinated against COVID-19 during the omicron wave had decreased risks for preterm birth and adverse neonatal outcomes, according to results of the INTERCOVID-2022 study.

On Thursday, the U.S. Supreme Court ruled 9-0 that access to mifepristone for medication abortion remains legal including rules adopted since 2016 loosening original dispensing requirements and gestation limits.

BOSTON — Women exposed to a class of endocrine-disrupting chemicals known as PFAS may be more likely to struggle with breastfeeding, whereas the health effects of infant exposure to PFAS via breastmilk remain unknown, a speaker said.

The AMA adopted policies to protect patients’ access to necessary health care in a variety of ways at its annual meeting.

BOSTON — Evidence suggests hyperandrogenism is associated with changes in the gut microbiome in women with polycystic ovary syndrome and the gut microbiome may play a causal role in PCOS metabolic dysregulation, according to a speaker.

BOSTON — Midlife women reporting bothersome hot flashes are more likely to receive a diagnosis of metabolic dysfunction-associated steatotic liver disease regardless of hormone therapy use, according to a speaker.